$ENDV #Stocks #StockMarket #EndonovoTherapeutics issued Q4 EPS on https://t.co/savSNTKlN1: ENDV announced very strong Sales growth of 252.339 % Y/Y to $0.148 MM in the Q4, but rose loss at $-0.01. https://t.co/mFa9U0buFN